Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the Mu opioid receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 512-520

  Ammer, Hermann ^a   Schulz, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; CYANOPINDOLOL; ISOPRENALINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PERTUSSIS TOXIN; PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MORPHINE ADDICTION; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; CELLS, CULTURED; CYCLIC AMP; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; HUMANS; ISOPROTERENOL; MORPHINE; RATS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, OPIOID, MU; SUBSTANCE WITHDRAWAL SYNDROME; TRANSFECTION; UP-REGULATION;

EID: 0031000156     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. AMMER, H. AND SCHULZ, R: Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy μ-opioids. Biochem. J. 295: 263-271, 1993a.
2. S is enhanced in neuroblastoma × glioma (NG108-15) hybrid cells chronically exposed to an opioid. Mol. Pharmacol. 43: 556-563, 1993b.
3. 1 receptor system in neuroblastoma × glioma (NG108-15) hybrid cells. J. Neurochem. 64: 2449-2457, 1995.
4. 1 receptors and stimulatory G proteins. Brain Res. 707: 235-244, 1996.
5. AVIDOR-REISS, T., BAYEWITCH, M., LEVY, R., MATUS-LEIBOVITCH, N., NEVO, I. AND VOGEL, Z.: Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270: 29732-29738, 1995.
6. 2A cells stably expressing a cloned μ-opioid receptor: A specific cellular model to study acute and chronic effects of morphine. Mol. Brain. Res. 30: 269-278, 1995.
7. CHEN, Y., MESTEK, A., LIU, J., HURLEY, J. A. AND YU, L.: Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44: 8-12, 1993.
8. CHILDERS, S. R.: Opioid receptor-coupled second messenger systems. Life Sci. 48: 1991-2003, 1991.
9. COLLIER, H. O. J.: Cellular site of opiate dependence. Nature (Lond.) 283: 625-629, 1980.
10. COLLIER, H. O. J.: Cellular aspects of opioid tolerance and dependence. In Opioids: Past, Present and Future, ed. by J. Hughes, pp. 109-125, Taylor and Francis Ltd., London, 1984.
11. DELAVIER-KLUTCHKO, C., HOEBEKE, J. AND STROSRERG, D.: The human carcinoma cell line A431 possesses large numbers of functional β-adrenergic receptors. FEBS Lett. 169: 151-155, 1984.
12. DUMAN, R. S., TALLMAN, J. F. AND NESTLER, E. J.: Acute and chronic opiate-regulation of adenylate cyclase in brain: Special effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246: 1033-1039, 1988.
13. FRANDSEN, E. K. AND KRISHNA, G.: A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. Lif Sci. 18: 529-542, 1977.
14. FUNADA, M., SUZUKI, T., SUGANO, Y., TSUBAI, M., MISAWA, M., UEDA, H. AND MISU, Y.: Role of β-adrenoceptors in the expression of morphine withdrawal signs. Life Sci. 54: 113-118, 1994.
15. GILMAN, A. G.: G proteins: Transducers of receptor generated signals. Annu. Rev. Biochem. 56: 615-649, 1987.
16. GRIFFIN, M. T., LAW, P. Y. AND LOH, H. H.: Involvement of both inhibitory and stimulatory guanine nucleotide binding proteins in the expression of chronic opiate regulation of adenylate cyclase in NG108-15 cells. J. Neurochem. 45: 1585-1589, 1985.
17. HARRIS, G. C. AND ASTON-JONES, G.: Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology 9: 303-311, 1993.
18. JOHNSON, S. M. AND FLEMING, W. W.: Mechanisms of cellular adaptive sensitivity changes: Applications to opioid tolerance and dependence. Pharmacol. Rev. 41: 435-488, 1989.
19. LAW, P. Y., HOM, D. S. AND LOH, H. H.: Opiate receptor down-regulation and desensitization in neuroblastoma × glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24: 413-424, 1983.
20. LAW, P. Y., HUM, D. S. AND LOH, H. H.: Down-regulation of opiate receptor in neuroblastoma × glioma NG108-15 hybrid cells: Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J. Biol. Chem. 259: 4096-4104, 1984.
21. LAW, P. Y., KOEHLER, J. E. AND LOH, H. H.: Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18TG2 and neuroblastoma × glioma NG108-15 cell lines. Mol. Pharmacol. 21: 483-491, 1982.
22. LAW, P. Y., MCGINN, T. M., WICK, M. J., ERIKSON, L. J., EVANS, C. AND LOH, H. H.: Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: Function of receptor density? J. Pharmacol. Exp. Ther. 271: 1686-1694, 1994.
23. 2-drenergic receptors in mammalian cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 345: 444-451, 1992.
24. MAY, D. C., ROSS, E. M., GILMAN, A. G. AND SMIGEL, M. C.: Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J. Biol. Chem, 260: 15829-15833, 1985.
25. NESTLER, E. J.: Molecular mechanisms of drug action. J. Neurosci. 12: 2439-2450, 1992.
26. PEI, G., KIEFFER, B. L., LEFKOWITZ, R. J. AND FREEDMAN, N. J.: Agonist-dependent phosphorylation of the mouse δ-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48: 173-177, 1995.
27. PETERSON, G. L.: Determination of total protein. Meth. Enzymol. 91: 95-119, 1983.
28. 2-adrenergic receptor. Mol. Pharmacol. 45: 390-394, 1994.
29. SCATOHARD, G.: The attractions of proteins for small molecules and ions. Ann. N Y Acad. Sci. 51: 660-672, 1949.
30. SHARMA, S. K., KLEE, W. A. AND NIRENBERG, M.: Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 72: 3092-3096, 1975.
31. S carboxyl-terminal decapeptide. FEBS Lett. 249: 189-194, 1989.
32. THOMAS, J. M. AND HOFFMAN, B. B.: Adenylate cyclase supersensitivity: A general means of cellular adaptation to inhibitory agonists? Trends Pharmacol. Sci. 8: 308-311, 1987.
33. TRABER, J., GULLIS, J. R. AND HAMPRECHT, B.: Cyclic nucleotides in cell cultures of the nervous system. Fed. Proc. 41: 165-177, 1975.
34. VACHON, L., COSTA, T. AND HERZ, A.: GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. Mol. Pharmacol. 31: 159-168, 1987.
35. VAN VLIET, B. J., DE VRIES, T. J., WARDEH, G., MILDER, A. H. AND SCHOFFELMER, A. N. M.: μ-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. Eur. J. Pharmacol. Mol. Pharmacol. 208: 105-111, 1991.
36. WHALEY, B. S., YUAN, N., BIRNBAUMER, L., CLARK, R. B. AND BARBER, R.: Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: A quantitative evaluation. Mol. Pharmacol. 45: 481-489, 1994.
37. WÜSTER, M., SCHULZ, R. AND HERZ, A.: Opiate tolerance and dependence: Reevaluating the unitary hypothesis. Trends Pharmacol. Sci. 6: 64-67, 1985.
38. YU, V. C., EIGER, S., DUAN. D. S., LAMEH, J. AND SADÉE, W.: Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells. J. Neurochem. 55: 1390-1396, 1990.